HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuaki Tatsumi Selected Research

Hemochromatosis (Bronze Diabetes)

4/2024A Revised Classification of Primary Iron Overload Syndromes.
3/2021Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
3/2021Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism.
8/2020Juvenile Hemochromatosis: A Case Report and Review of the Literature.
8/2018The interactions between iron and copper in genetic iron overload syndromes and primary copper toxicoses in Japan.
3/2017Iron overload patients with unknown etiology from national survey in Japan.
7/2016PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus.
6/2014A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.
9/2012Clinicopathological study of Japanese patients with genetic iron overload syndromes.
11/2011Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuaki Tatsumi Research Topics

Disease

17Iron Overload
04/2024 - 06/2009
12Hemochromatosis (Bronze Diabetes)
04/2024 - 01/2010
9Hepatolenticular Degeneration (Wilson's Disease)
12/2019 - 06/2009
5Anemia
04/2024 - 02/2014
4Fibrosis (Cirrhosis)
02/2024 - 09/2011
4Hyperferritinemia
03/2021 - 11/2010
4Liver Diseases (Liver Disease)
03/2017 - 06/2009
4Neoplasms (Cancer)
05/2008 - 03/2002
3Liver Cirrhosis (Hepatic Cirrhosis)
08/2020 - 01/2020
3type 2 Hemochromatosis
08/2020 - 03/2012
3Liver Failure
08/2018 - 01/2010
2Diabetic Neuropathies (Diabetic Neuropathy)
10/2019 - 05/2019
2Melanoma (Melanoma, Malignant)
12/2006 - 03/2002
1Inflammation (Inflammations)
02/2024
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021
1Heart Failure
08/2020
1Fatigue
01/2020
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Hypoglycemia (Reactive Hypoglycemia)
10/2019
1Atrophy
10/2018
1Inborn Genetic Diseases (Disease, Hereditary)
08/2018
1Nervous System Diseases (Neurological Disorders)
01/2017
1Insulin Resistance
01/2017
1Diabetes Mellitus
07/2016
1Hemolytic Anemia
07/2016
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2010
1Hepatitis
01/2010
1Chronic Hepatitis C
01/2010
1Brain Diseases (Brain Disorder)
01/2010
1Fatty Liver
06/2009
1Chronic Hepatitis (Chronic Active Hepatitis)
03/2009
1Hyperglycemia
05/2008
1Body Weight (Weight, Body)
05/2003
1Lung Neoplasms (Lung Cancer)
03/2002
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2002
1Neuroblastoma
03/2002
1Stomach Neoplasms (Stomach Cancer)
03/2002
1Colorectal Neoplasms (Colorectal Cancer)
03/2002
1Asthma (Bronchial Asthma)
02/2002

Drug/Important Bio-Agent (IBA)

17IronIBA
04/2024 - 01/2010
11CopperIBA
01/2024 - 06/2009
9metal transporting protein 1 (ferroportin)IBA
04/2024 - 11/2010
7Familial apoceruloplasmin deficiencyIBA
04/2024 - 06/2009
6HepcidinsIBA
08/2020 - 01/2010
4Ferritins (Ferritin)IBA
01/2020 - 01/2010
3Transferrin (beta 2 Transferrin)IBA
04/2024 - 01/2020
3Ceruloplasmin (Ferroxidase)IBA
08/2018 - 06/2012
3Idiopathic Copper ToxicosisIBA
09/2013 - 09/2011
2HemosiderinIBA
01/2024 - 12/2017
2Transaminases (Aminotransferases)IBA
01/2020 - 01/2010
2Alanine Transaminase (SGPT)IBA
12/2019 - 12/2015
2EnzymesIBA
02/2014 - 01/2010
1MetalsIBA
04/2024
1Pyruvic Acid (Pyruvate)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2019
1Neuroprotective AgentsIBA
05/2019
1Transferrin Receptors (Transferrin Receptor)IBA
03/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1Nonesterified Fatty Acids (NEFA)IBA
01/2017
1copper oxidaseIBA
01/2017
1Phosphatidylcholines (Phosphatidylcholine)IBA
07/2016
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2015
1DeferasiroxFDA Link
11/2011
1Biomarkers (Surrogate Marker)IBA
11/2010
1Fixatives (Pickling Agents)IBA
06/2009
1Coloring Agents (Dyes)IBA
06/2009
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
03/2009
1Phorbol EstersIBA
05/2008
1Protein Kinase CIBA
05/2008
1Transcription Factors (Transcription Factor)IBA
05/2008
1NF-kappa B (NF-kB)IBA
05/2008
1Protein Kinases (Protein Kinase)IBA
12/2006
1ArsenicIBA
12/2006
1arseniteIBA
12/2006
1Proteins (Proteins, Gene)FDA Link
12/2006
1Histones (Histone)IBA
12/2006
1Phosphotransferases (Kinase)IBA
06/2006
1Mitogen-Activated Protein KinasesIBA
06/2006
1PaxillinIBA
06/2006
1Tyrosine (L-Tyrosine)FDA Link
06/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2003
1Shiga Toxin 2IBA
05/2003
1Messenger RNA (mRNA)IBA
03/2002
1GangliosidesIBA
03/2002
1G(M2) Ganglioside (Ganglioside GM2)IBA
03/2002
1SialyltransferasesIBA
03/2002
1(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA
03/2002
1GD2 gangliosideIBA
03/2002
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
02/2002
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2002
1Phosphodiesterase 4 InhibitorsIBA
02/2002
1Theophylline (Theon)FDA LinkGeneric
02/2002
1RolipramIBA
02/2002
13,4- dipropyl- 4,5,7,8- tetrahydro- 3H- imidazo(1,2- i)purin- 5- oneIBA
02/2002

Therapy/Procedure

3Chelation Therapy (Therapy, Chelation)
03/2017 - 11/2011
3Therapeutics
01/2010 - 03/2002
1Slit Lamp
06/2012
1Drug Therapy (Chemotherapy)
01/2010
1Intravenous Administration
05/2003